Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Documenti analoghi

• Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector
  di: Mingozzi, Federico, et al.
  Pubblicazione: (2002)
• Absence of Circulating Factor IX Antigen in Hemophilia B Dogs of the UNC-Chapel Hill Colony
  di: Herzog, Roland W., et al.
  Pubblicazione: (2000)
• Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
  di: Arruda, Valder R., et al.
  Pubblicazione: (2005)
• Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
  di: Arruda, Valder R., et al.
  Pubblicazione: (2010)
• Translational Data from Adeno-Associated Virus-Mediated Gene Therapy of Hemophilia B in Dogs
  di: Nichols, Timothy C., et al.
  Pubblicazione: (2015)